Chemoinformaics analysis of 4(8)-diene
Molecular Weight | 220.356 | nRot | 0 |
Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
Exact Molecular Weight | 220.183 | nRing | 2 |
Solubility: LogS | -4.811 | nHRing | 1 |
Solubility: LogP | 5.714 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 0 | BPOL | 25.813 |
QED | 0.435 |
Synth | 4.123 |
Natural Product Likeliness | 3.041 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.857 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.481 |
MDCK | 0.0000173 |
BBB | 0.129 |
PPB | 0.966295 |
VDSS | 3.816 |
FU | 0.0364248 |
CYP1A2-inh | 0.259 |
CYP1A2-sub | 0.199 |
CYP2c19-inh | 0.241 |
CYP2c19-sub | 0.811 |
CYP2c9-inh | 0.189 |
CYP2c9-sub | 0.384 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.363 |
CYP3a4-inh | 0.169 |
CYP3a4-sub | 0.2 |
CL | 17.923 |
T12 | 0.128 |
hERG | 0.03 |
Ames | 0.009 |
ROA | 0.024 |
SkinSen | 0.944 |
Carcinogencity | 0.835 |
EI | 0.769 |
Respiratory | 0.058 |
NR-Aromatase | 0.071 |
Antiviral | Yes |
Prediction | 0.798017 |